GC
Insider
GC Corp.
10% ownerGC Corp. (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Artiva Biotherapeutics, Inc. (ARTV). Across 1 priced purchase filing, the average 21-session return was -37.8% from execution and +26.2% from disclosure (delay-adjusted; derived). The largest single filing was $16.5M of ARTV (1,432,291 sh across 2 lots, as filed), executed May 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-37.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+26.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells · 1 late
Median delay
17d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$16.5M
shares × price, as filed
Last traded
May 11
Filed May 28
Median ADV $6.3M across their filed names
Open performance→Volume by month
Buys $16.5M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ARTVRecent filings
ARTVPURCHASE
Artiva Biotherapeutics, Inc.
View filing →
$16.5M1,432,291 sh across 2 lots
Exec May 11
Filed May 28 · 4:34 PM ET †